Viewing Study NCT07347327


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-04-01 @ 5:20 PM
Study NCT ID: NCT07347327
Status: COMPLETED
Last Update Posted: 2026-01-22
First Post: 2026-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke
Sponsor: Ke Dong, MD
Organization:

Study Overview

Official Title: The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke
Status: COMPLETED
Status Verified Date: 2026-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This clinical trial aims to study whether dual-target transcranial alternating current stimulation (tACS) applied to the auditory and motor brain region can improve repetition disorder in people with stroke, and to evaluate the safety of tACS. The main goals are to answer the following questions:

1. Can dual-tACS stimulation of the auditory and motor brain area improve repetition functions in people with aphasia after stroke?
2. Can it improve the integration of auditory information and speech motor control during communication?

Researchers will compare the effects of real tACS versus sham (placebo) stimulation to see if real stimulation leads to better outcomes in aphasia patients.

Participants will:

1. Receive one extra 20-minute session of either real or sham tACS each day for 10 days
2. Attend clinic visits before and after 10-days stimulation for clinical assessments(WAB) and fNIRS recording related brain activity
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: